Search

By using melamine as a precursor for the copolymerization process, g-C3N4 and g-C3N4/TCNQ/Eu complexes with various amounts of doping were created. These complexes were then examined using XRD, FT-IR, SEM, TEM, XPS, PL, UV-vis, and I-T. The degradation rates of pefloxacin (PEF), enrofloxacin (ENR), and ciprofloxacin (CIP) were 91.1%, 90.8%, and 93.2% under visible light (λ > 550 nm). The photocatalytic performance of the composite was analyzed, and the best effect was obtained for CIP photocatalysis when Eu doping was 3 mg at 20 °C and pH 7. Kinetic analysis showed that there was a linear relationship between the sample and the photocatalytic time, and the degradation rate was about 5 times that of g-C3N4. The cyclic stability of the g-C3N4/TCNQ/Eu composite sample was found to be good through repeated experiments. UPLC-MS visualizes the degradation process of CIP. The extremely low stability of piperazine ring induced subsequent degradation, followed by the fracture of quinolone ring promoting the complete decomposition of CIP.

g-C3N4 and g-C3N4/TCNQ composites with different doping levels were prepared using the copolymerization thermal method with melamine as a precursor. XRD, FT-IR, SEM, TEM, DRS, PL, and I-T characterized them. The composites were successfully prepared in this study. The photocatalytic degradation of pefloxacin (PEF), enrofloxacin (ciprofloxacin), and ciprofloxacin (ciprofloxacin) under visible light (λ > 550 nm) showed that the composite material had the best degradation effect on PEF. When TCNQ doping is 20 mg and catalyst dosage is 50 mg, the catalytic effect is the best, and the degradation rate reaches 91.6%, k = 0.0111 min−1, which is four times that of g-C3N4. Repeated experiments found that the cyclic stability of the g-C3N4/TCNQ composite was good. The XRD images were almost unchanged after five reactions. The radical capture experiments revealed that ·O2− was the main active species in the g-C3N4/TCNQ catalytic system, and h+ also played a role in PEF degradation. And the possible mechanism for PEF degradation was speculated.

Abstract Background The goal of this study was to further investigate the clinical effectiveness of the T-SPOT.TB test in diagnosing tuberculosis (TB), including the effects of T-SPOT.TB test on evaluating diverse TB types and locations. Methods We collected 20,332 specimens from patients suspected to have TB. Afterwards, we performed an integrative analysis of T-SPOT.TB results and clinical diagnoses, and evaluated the composition ratio and positive detection rate of the T-SPOT.TB test in various age groups, sample types, and hospital departments. In addition, we compared the spot number and composition rate between latent TB infection (LTBI), active TB infection, and old TB infection groups. The active TB group was then further divided into pulmonary TB (PTB), pulmonary and extrapulmonary TB (PETB), and extrapulmonary TB (EPTB) subgroups, and we evaluated whether there were statistical differences in spot number and composition rate between subgroups. Results Positive results from the T-SPOT.TB test were found across different age groups, specimen types, and hospital departments. Elderly patient groups, pleural effusion samples, and thoracic surgery departments showed the highest rates of positivity. There were no statistically significant differences in spot number of CFP-10 and ESAT-6 wells between disease groups or active TB subgroups. The composition rate, however, was significantly different when ESAT-6 and CFP-10 wells were double-positive. The spot number and composition rate were statistically different between the three disease groups, but showed no significant differences between the three subgroups of active TB. Conclusions The results of T-SPOT. TB test showed differences in LTBI, active TB and old TB. Additionally, a higher spot number level was observed in the active TB group.